Bolt Biotherapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Bolt Biotherapeutics Inc
TickerBOLT
CIK #0001641281
CUSIP097698104
SectorLife Sciences - Pharmaceutical Preparations
Address900 Chesapeake Drive, Redwood City, CA 94063
Source [EDGAR]
CIK Filing 2011 - 2024
[0001641281] 10-K
[0001641281] 10-Q
[0001641281] 3
[0001641281] 4
[0001641281] 5
[0001641281] 8-K
[0001641281] D
[0001641281] SC 13D
[0001641281] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Tang Capital Partners LP Bolt Biotherapeutics Inc [2023-04-20] 7.2
Suvretta Capital Management LLC Bolt Biotherapeutics Inc [2021-11-29] 6.0
RA Capital Management LP Bolt Biotherapeutics Inc [2021-04-07] 6.5
Citadel Advisors LLC Bolt Biotherapeutics Inc [2021-02-19] 8.1
Vivo Capital VIII LLC Bolt Biotherapeutics Inc [2021-02-18] 6.6
Pivotal Bioventure Partners Fund I LP Bolt Biotherapeutics Inc [2021-02-17] 5.5
Sofinnova Venture Partners X LP Bolt Biotherapeutics Inc [2021-02-16] 11.0
Novo Holdings A/S Bolt Biotherapeutics Inc [2021-02-11] 13.0
Form 3/4/5 Filer 2011 - 2024
Bolt Biotherapeutics, Inc.
Laporte Kathleen
Berner Laura
Engleman Edgar
Healy James
Shah Mahendra
Onetto Nicole
O'Callaghan Brian
Miller Richard A MD
Lee Frank D.
Yonehiro Grant
Quinn William P.
Perez Edith A.
Schatzman Randall C
Novo Holdings A/S
Dornan David
Vivo Capital Fund VIII, L.P.
Vivo Opportunity, LLC
Vivo Opportunity Fund, L.P.
Vivo Panda, LLC
Vivo Capital VIII, LLC
Vivo Panda Fund, L.P.
Vivo Capital Surplus Fund VIII, L.P.
Khanna Ashish Siri Ram
Powell Michael
Sofinnova Venture Partners X, L.P.
Sofinnova Management X, L.P.
Katabi Maha
Moldt Peter
Form 13F Holdings
Firm Period DFND Voting Shares
Vivo Capital LLC [2023-03-31] SOLE 3,871,291.0 3,871,291.0
Citadel Advisors LLC [2023-03-31] DFND 2,838,445.0 2,838,445.0
Sofinnova Investments Inc [2023-03-31] SOLE 2,754,437.0 2,754,437.0
Pivotal Bioventure Partners Investment Advisor LLC [2023-03-31] DFND 0.0 1,891,467.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 1,627,553.0
OrbiMed Advisors LLC [2023-03-31] SOLE 1,541,000.0 1,541,000.0
Nan Fung Group Holdings Ltd [2023-03-31] DFND 1,166,952.0 1,166,952.0
Newtyn Management LLC [2023-03-31] SOLE 1,115,110.0 1,115,110.0
Samsara Biocapital LLC [2023-03-31] SOLE 1,049,153.0 1,049,153.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 924,265.0
Board of Trustees of The Leland Stanford Junior University [2023-03-31] SOLE 719,546.0 719,546.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 500,000.0 500,000.0
Renaissance Technologies LLC [2023-03-31] SOLE 155,339.0 456,739.0
Hawkeye Capital Management LLC [2023-03-31] SOLE 415,039.0 415,039.0
Morgan Stanley [2023-03-31] DFND 276,033.0 306,402.0
Goldman Sachs Group Inc [2023-03-31] DFND 283,085.0 283,085.0
BlackRock Inc. [2023-03-31] SOLE 274,430.0 274,430.0
Millennium Management LLC [2023-03-31] SOLE 245,411.0 245,411.0
Assenagon Asset Management S.A. [2023-03-31] SOLE 225,816.0 225,816.0
JPMorgan Chase & Co [2023-03-31] DFND 189,306.0 189,306.0
Geode Capital Management LLC [2023-03-31] DFND 177,992.0 177,992.0
Velan Capital Investment Management LP [2023-03-31] SOLE 140,000.0 140,000.0
Privium Fund Management UK Ltd [2023-03-31] SOLE 116,516.0 116,516.0
Marquette Asset Management LLC [2023-03-31] SOLE 0.0 97,835.0
FMR LLC [2023-03-31] DFND 78,391.0 78,433.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 75,200.0 75,200.0
State Street Corp [2023-03-31] DFND 48,737.0 48,737.0
Northern Trust Corp [2023-03-31] DFND 0.0 31,182.0
Bailard Inc [2023-03-31] SOLE 28,500.0 28,500.0
Man Group plc [2023-03-31] DFND 25,367.0 25,367.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com